艾力斯

Advancing Long Life with
Innovation of Science and Technology
An innovative
biopharmaceutical company

Develop first-in-class Drug against King of Cancer

2021/07/28
Furmonertinib Listed in Beijing Supplemental Medical Insurance Program

2021/07/26
Du Jinhao, Chairman of Allist, was Invited to Give a Speech at the Forum for Scientific & Innovative Enterprises hosted by Li Qiang, Secretary of Shanghai Municipal Party Committee

2021/07/23
The first subject enrolled in the FORWARD research on Furmonertinib-based adjuvant treatment

2021/07/02
Never forget why we started, never stop where we pursue

2021/06/11
Furmonertinib added to Qindao e-Insurance coverage rolled out on Mother’s Day

2021/05/09

We focus on scientific exploration and drug development in the field of oncology treatment